Advertisement

Inflammopharmacology

, Volume 27, Issue 1, pp 67–76 | Cite as

The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial

  • Hadi Bazyar
  • Hassan Gholinezhad
  • Leila Moradi
  • Parvin Salehi
  • Faezeh Abadi
  • Maryam Ravanbakhsh
  • Ahmad Zare JavidEmail author
Original Article

Abstract

Background

Diabetes mellitus (DM) and periodontitis are two common chronic diseases with bidirectional relationship. Oxidative stress plays a key role in the pathogenesis of these two diseases. The aim of this study was to investigate the effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 DM patients with chronic periodontitis (CP).

Materials and methods

In this double-blind clinical trial study, 50 type 2 DM patients with CP were randomly allocated to the intervention and control groups. The intervention and control groups received either 6 mg melatonin or placebo (2 tablets) once a day. Serum levels of melatonin, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), hs-C-reactive protein (hs-CRP), clinical attachment loss (CAL), pocket depth (PD), bleeding on probing (BOP) and plaque index were evaluated in all subjects pre- and post-intervention.

Results

Melatonin supplementation significantly increased the mean serum levels of melatonin after intervention. The mean changes of melatonin were significantly higher in intervention group compared with control group. IL-6 and hs-CRP levels were significantly (p = 0.008 and p = 0.017, respectively) reduced in the intervention group. The mean changes of IL-6 were significantly lower in the intervention group compared with the control group (p = 0.04). In the intervention group, PD and CAL were significantly decreased after intervention (p < 0.001). There were significant differences in the mean change of PD and CAL between the intervention and control groups after intervention (p < 0.001).

Conclusions

Melatonin supplementation in adjunct with non-surgical periodontal therapy might improve inflammatory and periodontal status in T2DM with CP.

Keywords

Type 2 diabetes mellitus Periodontal disease Melatonin Inflammatory markers 

Abbreviations

DM

Diabetes mellitus

CP

Chronic periodontitis

TNF-α

Tumor necrosis factor-alpha

IL-6

Interleukin-6

hs-CRP

hs-C-reactive protein

CAL

Clinical attachment loss

BOP

Bleeding on probing

PD

Pocket depth

NSPT

Non-surgical periodontal therapy

WC

Waist circumference

HC

Hip circumference

WHR

Waist to hip ratio

Notes

Acknowledgements

This study is part of the M.Sc. thesis of MR Bazyar. This work was financially supported by a grant (NRC-9507) from the Vice-Chancellor for Research Affairs of Ahvaz Jundishapur University of Medical Sciences. The authors thank the Nutrition and Metabolic Disorders Research Center, and Research Center of Diabetes, Endocrinology and Metabolism clinic employees of Ahvaz University Golestan Hospital and Dental Clinic of Ahvaz Jundishapur University of Medical Sciences.

Compliance with ethical standards

Conflict of interest

The authors have declared that there is no conflict of interest.

References

  1. Abdolsamadi H, Goodarzi MT, Motemayel FA, Jazaeri M, Feradmal J, Zarabadi M, Hoseyni M, Torkzaban P (2014) Reduction of melatonin level in patients with type II diabetes and periodontal diseases. J Dent Res Dent Clin Dent Prospect 8(3):160Google Scholar
  2. Alamdari NM, Mahdavi R, Roshanravan N, Yaghin NL, Ostadrahimi A, Faramarzi E (2015) A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women. Horm Metab Res 47(07):504–508Google Scholar
  3. Almughrabi O, Marzouk K, Hasanato R, Shafik S (2013) Melatonin levels in periodontal health and disease. J Periodontal Res 48(3):315–321CrossRefGoogle Scholar
  4. Amin AH, El-Missiry MA, Othman AI (2015) Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis. Eur J Pharmacol 747:166–173CrossRefGoogle Scholar
  5. Annamalai S, Mohanam L, Alwin D, Prabhu V (2016) Effect of combination therapy of melatonin and orlistat on high fat diet induced changes in lipid profiles and liver function parameters in serum of rats. Obes Med 2:41–45CrossRefGoogle Scholar
  6. Babaei H, Forouzandeh F, Maghsoumi-Norouzabad L, Yousefimanesh HA, Ravanbakhsh M, Zare Javid A 2018. Effects of chicory leaf extract on serum oxidative stress markers, lipid profile and periodontal status in patients with chronic periodontitis. J Am Coll Nutr 37(6):479–486CrossRefGoogle Scholar
  7. Balaji TM, Vasanthi HR, Rao SR (2015) Gingival, plasma and salivary levels of melatonin in periodontally healthy individuals and chronic periodontitis patients: a pilot study. JCDR 9(3):ZC23Google Scholar
  8. Balci Yuce H, Karatas O, Aydemir Turkal H, Pirim Gorgun E, Ocakli S, Benli I, Cayli S (2016) The effect of melatonin on bone loss, diabetic control, and apoptosis in rats with diabetes with ligature-induced periodontitis. J Periodontol 87(4):e35–e43CrossRefGoogle Scholar
  9. Botero JE, Yepes FL, Roldán N, Castrillón CA, Hincapie JP, Ochoa SP, Ospina CA, Becerra MA, Jaramillo A, Gutierrez SJ (2012) Tooth and periodontal clinical attachment loss are associated with hyperglycemia in patients with diabetes. J Periodontol 83(10):1245–1250CrossRefGoogle Scholar
  10. Cardinali DP, Ladizesky MG, Boggio V, Cutrera RA, Mautalen C (2003) Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res 34(2):81–87CrossRefGoogle Scholar
  11. Cutando A, De Gómez-Moreno G, Arana C, Acuña-CastrovIejo D, Reiter RJ (2007) Melatonin: potential functions in the oral cavity. J Periodontol 78(6):1094–1102CrossRefGoogle Scholar
  12. Cutando A, Aneiros-Fernández J, López-Valverde A, Arias-Santiago S, Aneiros-Cachaza J, Reiter RJ (2011) A new perspective in oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol 56(10):944–950CrossRefGoogle Scholar
  13. Cutando A, López-Valverde A, de Diego RG, de Vicente J, Reiter R, Fernández MH, Ferrera MJ (2014) Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease. Odontology 102(2):290–296Google Scholar
  14. Cutando A, Montero J, De GóMEZ-Diego R, Ferrera MJ, Lopez-Valverde A (2015) Effect of topical application of melatonin on serum levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in patients with type 1 or type 2 diabetes and periodontal disease. J Clin Exp Dent 7(5):e628Google Scholar
  15. Daniel R, Gokulanathan S, Shanmugasundaram N, Lakshmigandhan M, Kavin T (2012) Diabetes and periodontal disease. J Pharm Bioallied Sci 4(2):S280CrossRefGoogle Scholar
  16. Duarte PM, da Rocha M, Sampaio E, Mestnik MJ, Feres M, Figueiredo LC, Bastos MF, Faveri M (2010) Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol 81(7):1056–1063CrossRefGoogle Scholar
  17. Farhangi MA, Javid AZ, Dehghan P (2016) The effect of enriched chicory inulin on liver enzymes, calcium homeostasis and hematological parameters in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial. Prim Care Diabetes 10:265–271CrossRefGoogle Scholar
  18. Gh FM (2011) Evaluation of the reliability and validity of Azad-Fesharaki’s physical activity questionnaire (AFPAQ). Arak Med Univ J 14(56):36–44Google Scholar
  19. Grover HS, Luthra S (2013) Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease. J Indian Soc Periodontol 17(3):292CrossRefGoogle Scholar
  20. Gu Y, Walker C, Ryan ME, Payne JB, Golub LM (2012) Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine. J Oral Microbiol 4(1):19227CrossRefGoogle Scholar
  21. Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103(2):137–149CrossRefGoogle Scholar
  22. Gulle K, Akpolat M, Kurcer Z, Cengiz M, Baba F, Acikgoz S (2014) Multi-organ injuries caused by lipopolysaccharide-induced periodontal inflammation in rats: role of melatonin. J Periodontal Res 49(6):736–741CrossRefGoogle Scholar
  23. Hardeland R (2005) Atioxidative protection by melatonin. Endocrine 27(2):119–130CrossRefGoogle Scholar
  24. Hardeland R, Poeggeler B (2003) Non-vertebrate melatonin. J Pineal Res 34(4):233–241CrossRefGoogle Scholar
  25. Kim E-K, Lee SG, Choi Y-H, Won K-C, Moon JS, Merchant AT, Lee H-K (2013) Association between diabetes-related factors and clinical periodontal parameters in type-2 diabetes mellitus. BMC Oral Health 13(1):64CrossRefGoogle Scholar
  26. Li C-J, Lv L, Li H, Yu D-M (2012) Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovas Diabetol 11(1):73CrossRefGoogle Scholar
  27. Mahan L, Escott Stump S, Raymond J (2012) Krause’s food the nutrition care process (Krause’s food nutrition therapy). WB Saunders. Elsevier, PhiladelphiaGoogle Scholar
  28. Manjarrez-Gutierrez. G, Rocío HMJ, Bueno-Santoyo S, González-Ramírez M, Hernández J (2000) Changes in brain serotonin biosynthesis in rats with diabetes mellitus induced by streptozocin: effect of insulin treatment. Rev Investig Clin Organo Del Hos Enferm La Nutr 52(5):509–516Google Scholar
  29. Mohammadi S, Shakerhosseini R, Rastmanesh R, Jafarian K, Amiri Z, Jahangir F (2015) Effects of melatonin supplementation on weight and body fat mass percentage in overweight or obese people. J Qazvin Univ Med Sci 19(5):24–31Google Scholar
  30. Pakravan H, Ahmadian M, Fani A, Aghaee D, Brumanad S, Pakzad B (2017) The effects of melatonin in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Adv Biomed Res 6:40CrossRefGoogle Scholar
  31. Prieto AKC, Gomes-Filho JE, Azuma MM, Sivieri-Araújo G, Narciso LG, Souza JC, Ciarlini PC, Cintra LTA (2017) Influence of apical periodontitis on stress oxidative parameters in diabetic rats. J Endod 43(10):1651–1656CrossRefGoogle Scholar
  32. Radogna F, Diederich M, Ghibelli L (2010) Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80(12):1844–1852CrossRefGoogle Scholar
  33. Reiter RJ, Manchester L, Tan D-X (2005) Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition 21(9):920–924CrossRefGoogle Scholar
  34. Simonneaux V, Ribelayga C (2003) Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 55(2):325–395CrossRefGoogle Scholar
  35. Srinath R, Acharya AB, Thakur SL (2010) Salivary and gingival crevicular fluid melatonin in periodontal health and disease. J Periodontol 81(2):277–283CrossRefGoogle Scholar
  36. Van Dyke TE (2014) Commentary: periodontitis is characterized by an immuno-inflammatory host-mediated destruction of bone and connective tissues that support the teeth. J Periodontol 85(4):509–511CrossRefGoogle Scholar
  37. Yu G-M, Kubota H, Okita M, Maeda T (2017) The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells. PLoS One 12(5):e0178525CrossRefGoogle Scholar
  38. Zare Javid A, Seal C, Heasman P, Moynihan P (2014) Impact of a customised dietary intervention on antioxidant status, dietary intakes and periodontal indices in patients with adult periodontitis. J Hum Nutr Diet 27(6):523–532CrossRefGoogle Scholar
  39. Zare Javid A, Hormoznejad R, Yousefimanesh HA, Zakerkish M, Haghighi Zadeh MH, Ravanbakhsh M (2017) The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytother Res 31(1):108–114CrossRefGoogle Scholar
  40. Zare Javid A, Maghsoumi-Norouzabad L, Ashrafzadeh E, Yousefimanesh HA, Zakerkish M, Ahmadi Kangali K, Ravanbakhsh M, Babaei H (2018) Impact of cranberry juice enriched with omega-3 fatty acids adjunct with nonsurgical periodontal treatment on metabolic control and periodontal status in type 2 patients with diabetes with periodontal disease. J Am Coll Nutr 37:71–79CrossRefGoogle Scholar
  41. Zephy D, Ahmad J (2015) Type 2 diabetes mellitus: role of melatonin and oxidative stress. Diabetes Metaboli Syndr: Clin Res Rev 9(2):127–131CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Hadi Bazyar
    • 1
  • Hassan Gholinezhad
    • 1
  • Leila Moradi
    • 2
  • Parvin Salehi
    • 3
  • Faezeh Abadi
    • 4
  • Maryam Ravanbakhsh
    • 5
  • Ahmad Zare Javid
    • 6
    Email author
  1. 1.Student Research Committee, Department of Nutrition, Faculty of Paramedical SciencesAhvaz Jundishapur University of Medical SciencesAhvazIran
  2. 2.Health Research Institute, Diabetes Research CenterAhvaz Jundishapur University of Medical SciencesAhvazIran
  3. 3.Department of Periodontology, School of DentistryAhvaz Jundishapur University of Medical SciencesAhvazIran
  4. 4.Department of Medical Surgical Nursing, Nursing and Midwifery SchoolRafsanjan University of Medical SciencesRafsanjanIran
  5. 5.Student Research Committee, Department of Environmental Health Engineering, School of Public HealthAhvaz Jundishapur University of Medical SciencesAhvazIran
  6. 6.Nutrition and Metabolic Diseases Research Center & Hyperlipidemia Research CenterAhvaz Jundishapur University of Medical SciencesAhvazIran

Personalised recommendations